New Key Statistics Module, Z-Score and F-Score
SZSE:300497 Key Ratios
Market Cap ¥ M | 5,406.55 |
Enterprise Value ¥ M | 6,366.39 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 2.21 |
Price/Sales | 3.79 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) ¥ M | 1,436.00 |
EPS (TTM) ¥ | -0.30 |
Beneish M-Score | -2.7 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -43.97 |
EV-to-EBITDA | -43.97 |
PEG | -- |
Shares Outstanding M | 550.00 |
Net Margin (%) | -11.39 |
Operating Margin % | -6.17 |
Pre-tax Margin (%) | -13.00 |
Quick Ratio | 0.91 |
Current Ratio | 1.20 |
ROA % (ttm) | -3.40 |
ROE % (ttm) | -6.47 |
ROIC % (ttm) | -2.37 |
Dividend Yield % | -- |
Altman Z-Score | 1.79 |
SZSE:300497 Number of Guru Trades
SZSE:300497 Volume of Guru Trades
Gurus Latest Trades with SZSE:300497
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SZSE:300497 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Jiangxi Fushine Pharmaceutical Co Ltd Insider Transactions
No Available Data